Log in or Sign up for Free to view tailored content for your specialty!
Wound Management News
Americans spent more than $15 billion on aesthetic procedures in 2016
Americans spent more than $15 billion on combined surgical and nonsurgical aesthetic procedures in 2016, an increase of 11% over the prior year, according to the American Society for Aesthetic Plastic Surgery.
VIDEO: AAD launches SkinSerious campaign
ORLANDO, Fla. — In a video perspective from the American Academy of Dermatology Annual Meeting, Karen Edison, MD, FAAD, discusses the AAD’s SkinSerious campaign.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Economic burden of skin disease in the US
ORLANDO, Fla. — In a video perspective from the American Academy of Dermatology Annual Meeting, Henry W. Lim, MD, FAAD, discusses the economic burden of skin disease in the United States.
VIDEO: AAD president discusses 'highly successful' meeting
ORLANDO, Fla. — In a video perspective from the American Academy of Dermatology Annual Meeting, Henry W. Lim, MD, FAAD, discusses highlights from the meeting.
AAD installs new vice president, board members
ORLANDO, Fla. – The American Academy of Dermatology announced it has installed a new vice president and board members, who will take office at the end of its annual meeting.
Lim assumes presidency of AAD
ORLANDO, Fla. – Henry W. Lim, MD, FAAD, chair emeritus of the department of dermatology and senior vice president for Academic Affairs at Henry Ford Health System in Detroit, took office as president of the American Academy of Dermatology at its annual meeting.
Follow Healio.com/Dermatology's coverage of the 75th annual AAD meeting
ORLANDO – Healio.com/Dermatology is providing live coverage of the 75th annual American Academy of Dermatology Annual Meeting in Orlando beginning today.
Taksta noninferior to Zyvox in treating skin infections
Taksta oral tablets were noninferior to Zyvox in treating skin infections such as MRSA in a recent phase 3 clinical trial, the experimental drug’s manufacturer announced.
FDA permits RegeneRx licensee to conduct phase 3 trial for epidermolysis bullosa
RegeneRx Biopharmaceuticals announced in a press release that GtreeBNT Co., Ltd., has received a positive response from the FDA for a phase 3 clinical trial design for RGN-137 to treat epidermolysis bullosa.
Light therapy for wrinkles, FDA approval of Siliq top dermatology reads for week
Study results finding that low-level light therapy significantly and safely improved facial skin wrinkles was among the most-read articles of the past week on Healio.com/Dermatology.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read